Primaquine: its effect on cellular immune response of normal rhesus monkeys

The effect of primaquine on the cellular immune responses (lymphocyte subpopulations and their proliferative responses with PHA, Con-A and LPS, and phagocytosis by monocytes) of normal rhesus monkeys was studied under both in-vivo and in-vitro conditions. When the lymphocytes and monocytes from normal animals were treated in-vitro with primaquine, at concentration normally attainable during therapy, a significant inhibition in blastogenic response of lymphocytes and phagocytic capacity of monocytes was noticed after 4 hours of treatment. In contrast, the in-vivo effect of primaquine treatment on these cells was innocuous. From this study it is clear that the primaquine does not act as an immunosuppresant and can be given safely to any type of malaria patient.